Abstract:It is well established that the beta2-adrenergic receptor (beta2-AR) exhibits a robust ligand-independent activity, whereas this property is considerably weaker in the closely related beta1-AR subtype. To identify the potential domain(s) of beta2-AR responsible for the spontaneous receptor activation, we created three chimeras in which the third intracellular loop (beta1/beta2-Li3) or the carboxyl terminus (beta1/beta2-CT) or both domains (beta1/beta2-Li3CT) of beta1-AR are replaced by the corresponding parts of the beta2-AR. Using adenoviral gene transfer, we individually expressed these beta1/beta2-AR chimeras in mouse cardiomyocytes lacking both native beta1-AR and beta2-AR (beta1/beta2 double knockout), and examined their possible spontaneous activities. Overexpression of these beta1/beta2-AR chimeras markedly elevated basal cAMP accumulation and myocyte contractility in the absence of agonist stimulation compared with those infected by a control adenovirus expressing beta-galactosidase or an adenovirus expressing wild type beta1-AR. These effects were fully reversed by a beta2-AR inverse agonist, (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol (ICI 118,551; 5 x 10-7 M), regardless of inhibition of Gi with pertussis toxin, but not by a panel of beta1-AR antagonists, including [2-(3-carbamoyl-4-hydroxyphenoxy)-ethylamino]-3-[4-(1-methyl-4-trifluormethyl-2-imidazolyl)-phenoxy]-2-propanolmethanesulfonate (CGP20712A), betaxolol, bisoprolol, and metoprolol. Furthermore, we have shown that the C-terminal postsynaptic density 95/disc-large/ZO-1 (PDZ) motif of beta1-AR is not responsible for the lack of beta1-AR spontaneous activation, although it has been known that the beta1-AR PDZ motif prevents the receptor from undergoing agonist-induced trafficking and Gi coupling in cardiomyocytes. Taken together, the present results indicate that both the third intracellular loop and the C terminus are involved in beta2-AR spontaneous activation and that either domain seems to be sufficient to confer the receptor spontaneous activity.

Coupling and Activation of the β1 Adrenergic Receptor - The Role of the Third Intracellular Loop

Cellular lipids regulate the conformational ensembles of the disordered intracellular loop 3 in β2-adrenergic receptor

Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Analysis of β2AR-Gs and β2AR-Gi complex formation by NMR spectroscopy.

Autoregulation of GPCR signalling through the third intracellular loop

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

The Third Intracellular Loop and the Carboxyl Terminus of Beta2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor.

Analysis of <sub>2</sub>AR-G<sub>s</sub> and <sub>2</sub>AR-G<sub>i</sub> complex formation by NMR spectroscopy

Universal Properties and Specificities of the β2-Adrenergic Receptor-Gs Protein Complex Activation Mechanism Revealed by All-Atom Molecular Dynamics Simulations

Ligand-induced conformational changes in the β1-Adrenergic Receptor Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry

The Second Intracellular Loop of D2r Activates Galphai1

Conformational changes in the G protein Gs induced by the β2 adrenergic receptor

Structures of β1-adrenergic receptor in complex with Gs and ligands of different efficacies

Structure and dynamics determine G protein coupling specificity at a class A GPCR

Multiple Ligand-Specific Conformations of the Β2-Adrenergic Receptor

Analysis of Β 2 AR-G S and Β 2 AR-G I Complex Formation by NMR Spectroscopy

Structure and function of an intermediate GPCR-Gαβγ complex

Function and Dynamics of the Intrinsically Disordered Carboxyl Terminus of Β2 Adrenergic Receptor.

A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor